Researchers are exploring various treatments for colorectal cancer, including KRAS-targeted therapies and tumor vaccines. Some studies are investigating the use of these treatments in combination with other therapies, while others are examining their potential in pancreatic cancer. Active and recruiting clinical trials are underway to test the efficacy of these approaches in patients with KRAS mutant colorectal cancer and other types of cancer.